Skip to main content
KPC PHARMACEUTICALS, INC. logo

KPC PHARMACEUTICALS, INC. — Investor Relations & Filings

Ticker · 600422 ISIN · CNE0000015P8 LEI · 3003007ZALHXKUFMKN96 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 2,727 across all filing types
Latest filing 2015-10-21 Board/Management Inform…
Country CN China
Listing Shanghai Stock Exchange 600422

About KPC PHARMACEUTICALS, INC.

https://en.kpc.com.cn/

KPC Pharmaceuticals, Inc. specializes in the research, development, and manufacturing of pharmaceutical products, with a significant focus on natural and botanical medicines. The company is a global leader in the production of artemisinin-based anti-malarial treatments, including artemether and its derivatives. Its portfolio encompasses a wide range of therapeutic areas, notably cardiovascular and cerebrovascular health, where it utilizes Panax notoginseng saponins as a core component. KPC integrates traditional medicinal knowledge with modern pharmacological techniques to develop standardized botanical extracts and chemical drugs. The organization operates extensive production facilities and research centers dedicated to drug discovery and quality control. Its business activities extend to the distribution of healthcare products and the provision of medical services, aiming to provide comprehensive health solutions through innovation in natural medicine and biotechnology.

Recent filings

Filing Released Lang Actions
独立董事提名人声明（平其能）
Board/Management Information Classification · 100% confidence The document is a formal statement nominating an independent director candidate for the company's board. It details the nominee's qualifications, independence criteria, and compliance with regulatory requirements. There are no financial statements, earnings data, or report attachments. The content focuses on board/management information, specifically the nomination of a board member. Therefore, the document fits the category of Board/Management Information (MANG). The document length is short and does not indicate an announcement of a report publication or regulatory filing, so it is not RPA or RNS.
2015-10-21 Chinese
独立董事提名人声明（郭云沛）
Board/Management Information Classification · 95% confidence The document is a formal statement nominating an independent director candidate for the company's board. It details the qualifications, independence criteria, and compliance with regulatory requirements for the nominee. There is no financial data, no mention of financial results, no report publication, or voting results. It is related to board/management information, specifically about board member nomination. Therefore, the document fits best under Board/Management Information (MANG). The document length is short and focused on nomination, not a full report or announcement of voting results.
2015-10-21 Chinese
2015年第四次临时股东大会资料
AGM Information Classification · 100% confidence The document is titled as materials for the 2015 fourth extraordinary shareholders meeting of Kunming Pharmaceutical Group Co., Ltd. It includes detailed agenda items, voting procedures, and candidate profiles for board and supervisory committee elections. The content focuses on shareholder meeting materials, including proposals for amendments to company bylaws, election of directors and supervisors, and related voting instructions. There is no financial data or earnings information, nor is it a transcript or announcement of financial results. The document is a presentation of materials shared for a specific shareholders meeting, which fits the definition of AGM Information (AGM-R). The document length is substantial and contains detailed meeting materials, not just an announcement or summary, so it is not a Report Publication Announcement (RPA).
2015-10-21 Chinese
独立董事提名人声明（张旭良）
Board/Management Information Classification · 95% confidence The document is a formal statement nominating an independent director candidate for the company's board. It details the qualifications, independence criteria, and compliance with regulatory requirements for the nominee. There is no financial data, no report or results, no meeting minutes, no voting results, and no mention of any report publication. The content is focused on board/management information, specifically about the nomination of a board member. Therefore, the document fits best under the category of Board/Management Information (MANG). The document length is short and it is a declaration rather than a report or announcement of a report, so it is not RPA or RNS.
2015-10-21 Chinese
独立董事候选人声明（郭云沛）
Board/Management Information Classification · 95% confidence The document is a declaration statement by an independent director candidate confirming qualifications, independence, and compliance with regulatory requirements. It is not a financial report, audit, or management announcement but a formal statement related to board membership candidacy. This fits best under Board/Management Information (MANG) as it pertains to board member nomination and qualifications.
2015-10-21 Chinese
独立董事提名人声明（屠鹏飞）
Board/Management Information Classification · 95% confidence The document is a formal statement nominating an independent director candidate for the company's board. It details the qualifications, independence criteria, and compliance with relevant laws and regulations for the nominee. There is no financial data, no report or announcement of financial results, no mention of shareholder votes, or any other financial or regulatory filing content. This document relates to board/management information, specifically about board member nomination and qualifications.
2015-10-21 Chinese

Browse filings by year

26 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.